Table 1.
Characteristics of the study groups
| GCs sensitive patient (n = 20) | GCs resistant patients (n = 20) | Controls (n = 20) | p | |
|---|---|---|---|---|
| Age (y)* | 43 ±8.2 | 43 ±9.3 | 40 ±5.3 | 0.410 |
| Sex, n (%) Male Female |
8 (40) 12 (60) |
9 (45) 11 (55) |
7 (35) 13 (65) |
0.337 |
| FEV1 (%)* Before prednisolone After prednisolone |
57 ±4.3 76.2 ±3.9 |
54.3 ±4.1 56.45 ±3.8 |
– – |
0.06 < 0.001 |
| Atopic status, n (%) Atopic Non-atopic |
12 (60) 8 (40) |
15 (75) 5 (25) |
– – |
0.311 |
*
Values are presented as mean standard deviation; FEV1 – forced expiratory volume in 1st second; GCs – glucocorticoids